G

Researcher Profile

Gary J. Bridger

🏛 25X4 Pharmaceuticals, Boston, MA

3

Publications

308

Citations

10

Co-Authors

3

Active Years

Publications

Open Access Journal Article Blood Jul 04, 2024

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Raffaele Badolato · Laia Alsina · Antoine Azar · Yves Bertrand +33 more

10.1182/blood.2023022658 49 citations

Journal Article Biochemical Pharmacology Feb 01, 2012

The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor

Renee M. Mosi · Virginia Anastassova · Jennifer Cox · Marilyn C. Darkes +12 more

10.1016/j.bcp.2011.11.020 44 citations

Open Access Journal Article Journal of Biological Chemistry Jan 01, 2004

Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor

Mette M. Rosenkilde · Lars-Ole Gerlach · Janus S. Jakobsen · Renato T. Skerlj +2 more

10.1074/jbc.m309546200 215 citations

Publication Timeline

2024

1

2012

1

2004

1

Frequent Co-Authors

Renato T. Skerlj

Rebecca S.Y. Wong

Anna Shcherbina

Virginia Anastassova

Zefferino Santucci